Bertulfo, Renato, JR. B.
HRN: 22-56-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
CEFTAZIDIME 1GM (VIAL)
02/10/2023
02/16/2023
IVT
120mg
Q12hrs
T/c Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes